MEDICINES
CUSTOMIZED
FOR AGE-RELATED
DISEASES

TARGETED Therapeutics
to extend health-span

MORE LIFE TO YEARS

Medicines working
if, where & when
needed

Powered by our drug discovery computational platform ALEMBIC™ and enabled by our proprietary chemistry engineering, Rubedo makes novel drugs designed to be selective, safe and well tolerated. 

Rubedo’s lead small molecules are engineered to be selectively activated in pathological cells that drive age-related diseases.

NEWSFEED

Rubedo collaborates with Cedars-Sinai on senolytic IPF program

Venture Capitalists Back Biotech Push to Combat Aging

Rubedo Life Sciences Closes $12M Seed Financing Led by Khosla Ventures

Rubedo featured among top senolytic companies in Nature Biotechnology

PIPELINE

The Possibilities Are Endless

INVESTORS

logo-khosla-venures copy@2x

CAREERS

We welcome all applicants regardless of gender, sexual orientation, ethnicity, race, education, age, or other personal characteristics

Rubedo Life Sciences , Inc

Silicon Valley, CA, USA

Copyright 2020 by Rubedo Life Sciences, inc